A Clinical study on the effect of the syrup of Parnayavani (Panikoorka) and Madhu (Honey) in Bronchial asthma.

The effect of the combination of Parnayavani [Plectranthus amboinicus (Lour.) Spreng.] and Madhu in Tamaka svasa with special reference to Bronchial asthma - a single group clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028730

Enrollment

Registered

2020-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: syrup of parnayavani [Plectranthus amboinicus (Lour.) Spreng.] and Madhu(both taken in equal quantity): 15ml of the syrup is administered orally twice daily to 20 participants recruite

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical signs and symptoms of Bronchial asthma of mild to moderate nature 2.patients having minimum 2 among: Dyspnoea, wheezing, Cough

Exclusion criteria

Exclusion criteria: Dyspnoea due to causes other than bronchial. Status asthmatics Diagnosed cases of lung infections Diagnosed cases of lung malignancy Patients under allopathic medication for asthma and those using inhalers Diabetes mellitus Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
improvement in the subjective and spirometric parameters of tamaka svasa(bronchial asthma)Timepoint: 30 days	—

Secondary

Measure	Time frame
blood parameters- TC, DC,ESR, Hb,RBSTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDrVivekP

V.P.S.V Ayurveda college, Kottakkal

drvivekp@gmail.com9446488354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026